The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Molecular Blood-Global Market Insights and Sales Trends 2025
Synopsis
Molecular testing provides fast and accurate results and the prescence of molecular tests has disrupted several testing markets over the past decade and a half. However, some segments have thrived and others are seeing mature growth levels.
The global Molecular Blood market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Molecular Blood in various end use industries. The expanding demands from the Blood Centers, Hospitals, Commercial/Private Laboratories and Military Blood Banks, are propelling Molecular Blood market. PCR, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the PCR-RFLP segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Molecular Blood, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Molecular Blood market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Molecular Blood market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Molecular Blood sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Molecular Blood covered in this report include Abbott Laboratories, QIAGEN, Roche Diagnostics, Hologic, Grifols, Siemens Healthcare, Becton, Dickinson, Danaher and Biomerieux, etc.
The global Molecular Blood market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
QIAGEN
Roche Diagnostics
Hologic
Grifols
Siemens Healthcare
Becton, Dickinson
Danaher
Biomerieux
Cepheid
Global Molecular Blood market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Molecular Blood market, Segment by Type:
PCR
PCR-RFLP
AS-PCR or PCR-SSP
Multiplex PCR
Real Time PCR
Sanger DNA Sequencing
Pyrosequencing
Global Molecular Blood market, by Application
Blood Centers
Hospitals
Commercial/Private Laboratories
Military Blood Banks
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Molecular Blood companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Molecular testing provides fast and accurate results and the prescence of molecular tests has disrupted several testing markets over the past decade and a half. However, some segments have thrived and others are seeing mature growth levels.
The global Molecular Blood market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Molecular Blood in various end use industries. The expanding demands from the Blood Centers, Hospitals, Commercial/Private Laboratories and Military Blood Banks, are propelling Molecular Blood market. PCR, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the PCR-RFLP segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Molecular Blood, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Molecular Blood market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Molecular Blood market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Molecular Blood sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Molecular Blood covered in this report include Abbott Laboratories, QIAGEN, Roche Diagnostics, Hologic, Grifols, Siemens Healthcare, Becton, Dickinson, Danaher and Biomerieux, etc.
The global Molecular Blood market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
QIAGEN
Roche Diagnostics
Hologic
Grifols
Siemens Healthcare
Becton, Dickinson
Danaher
Biomerieux
Cepheid
Global Molecular Blood market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Molecular Blood market, Segment by Type:
PCR
PCR-RFLP
AS-PCR or PCR-SSP
Multiplex PCR
Real Time PCR
Sanger DNA Sequencing
Pyrosequencing
Global Molecular Blood market, by Application
Blood Centers
Hospitals
Commercial/Private Laboratories
Military Blood Banks
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Molecular Blood companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Molecular Blood
1.1 Molecular Blood Market Overview
1.1.1 Molecular Blood Product Scope
1.1.2 Molecular Blood Market Status and Outlook
1.2 Global Molecular Blood Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Molecular Blood Market Size by Region (2018-2029)
1.4 Global Molecular Blood Historic Market Size by Region (2018-2023)
1.5 Global Molecular Blood Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Molecular Blood Market Size (2018-2029)
1.6.1 North America Molecular Blood Market Size (2018-2029)
1.6.2 Europe Molecular Blood Market Size (2018-2029)
1.6.3 Asia-Pacific Molecular Blood Market Size (2018-2029)
1.6.4 Latin America Molecular Blood Market Size (2018-2029)
1.6.5 Middle East & Africa Molecular Blood Market Size (2018-2029)
2 Molecular Blood Market by Type
2.1 Introduction
2.1.1 PCR
2.1.2 PCR-RFLP
2.1.3 AS-PCR or PCR-SSP
2.1.4 Multiplex PCR
2.1.5 Real Time PCR
2.1.6 Sanger DNA Sequencing
2.1.7 Pyrosequencing
2.2 Global Molecular Blood Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Molecular Blood Historic Market Size by Type (2018-2023)
2.2.2 Global Molecular Blood Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Molecular Blood Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Molecular Blood Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Molecular Blood Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Molecular Blood Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Molecular Blood Revenue Breakdown by Type (2018-2029)
3 Molecular Blood Market Overview by Application
3.1 Introduction
3.1.1 Blood Centers
3.1.2 Hospitals
3.1.3 Commercial/Private Laboratories
3.1.4 Military Blood Banks
3.1.5 Others
3.2 Global Molecular Blood Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Molecular Blood Historic Market Size by Application (2018-2023)
3.2.2 Global Molecular Blood Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Molecular Blood Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Molecular Blood Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Molecular Blood Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Molecular Blood Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Molecular Blood Revenue Breakdown by Application (2018-2029)
4 Molecular Blood Competition Analysis by Players
4.1 Global Molecular Blood Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Molecular Blood as of 2022)
4.3 Date of Key Players Enter into Molecular Blood Market
4.4 Global Top Players Molecular Blood Headquarters and Area Served
4.5 Key Players Molecular Blood Product Solution and Service
4.6 Competitive Status
4.6.1 Molecular Blood Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Molecular Blood Products, Services and Solutions
5.1.4 Abbott Laboratories Molecular Blood Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 QIAGEN
5.2.1 QIAGEN Profile
5.2.2 QIAGEN Main Business
5.2.3 QIAGEN Molecular Blood Products, Services and Solutions
5.2.4 QIAGEN Molecular Blood Revenue (US$ Million) & (2018-2023)
5.2.5 QIAGEN Recent Developments
5.3 Roche Diagnostics
5.3.1 Roche Diagnostics Profile
5.3.2 Roche Diagnostics Main Business
5.3.3 Roche Diagnostics Molecular Blood Products, Services and Solutions
5.3.4 Roche Diagnostics Molecular Blood Revenue (US$ Million) & (2018-2023)
5.3.5 Hologic Recent Developments
5.4 Hologic
5.4.1 Hologic Profile
5.4.2 Hologic Main Business
5.4.3 Hologic Molecular Blood Products, Services and Solutions
5.4.4 Hologic Molecular Blood Revenue (US$ Million) & (2018-2023)
5.4.5 Hologic Recent Developments
5.5 Grifols
5.5.1 Grifols Profile
5.5.2 Grifols Main Business
5.5.3 Grifols Molecular Blood Products, Services and Solutions
5.5.4 Grifols Molecular Blood Revenue (US$ Million) & (2018-2023)
5.5.5 Grifols Recent Developments
5.6 Siemens Healthcare
5.6.1 Siemens Healthcare Profile
5.6.2 Siemens Healthcare Main Business
5.6.3 Siemens Healthcare Molecular Blood Products, Services and Solutions
5.6.4 Siemens Healthcare Molecular Blood Revenue (US$ Million) & (2018-2023)
5.6.5 Siemens Healthcare Recent Developments
5.7 Becton, Dickinson
5.7.1 Becton, Dickinson Profile
5.7.2 Becton, Dickinson Main Business
5.7.3 Becton, Dickinson Molecular Blood Products, Services and Solutions
5.7.4 Becton, Dickinson Molecular Blood Revenue (US$ Million) & (2018-2023)
5.7.5 Becton, Dickinson Recent Developments
5.8 Danaher
5.8.1 Danaher Profile
5.8.2 Danaher Main Business
5.8.3 Danaher Molecular Blood Products, Services and Solutions
5.8.4 Danaher Molecular Blood Revenue (US$ Million) & (2018-2023)
5.8.5 Danaher Recent Developments
5.9 Biomerieux
5.9.1 Biomerieux Profile
5.9.2 Biomerieux Main Business
5.9.3 Biomerieux Molecular Blood Products, Services and Solutions
5.9.4 Biomerieux Molecular Blood Revenue (US$ Million) & (2018-2023)
5.9.5 Biomerieux Recent Developments
5.10 Cepheid
5.10.1 Cepheid Profile
5.10.2 Cepheid Main Business
5.10.3 Cepheid Molecular Blood Products, Services and Solutions
5.10.4 Cepheid Molecular Blood Revenue (US$ Million) & (2018-2023)
5.10.5 Cepheid Recent Developments
6 North America
6.1 North America Molecular Blood Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Molecular Blood Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Molecular Blood Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Molecular Blood Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Molecular Blood Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Molecular Blood Market Dynamics
11.1 Molecular Blood Industry Trends
11.2 Molecular Blood Market Drivers
11.3 Molecular Blood Market Challenges
11.4 Molecular Blood Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
